Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
Authors
Keywords
insulin structural engineering, insulin analogs, insulin molecular pharmacology
Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 42, Issue 8, Pages 620-639
Publisher
Elsevier BV
Online
2021-06-18
DOI
10.1016/j.tips.2021.05.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The promise of stem cell-derived islet replacement therapy
- (2021) Douglas Melton DIABETOLOGIA
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Matthias von Herrath et al. Lancet Diabetes & Endocrinology
- The future of insulin therapy
- (2021) Tim Heise DIABETES RESEARCH AND CLINICAL PRACTICE
- Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
- (2021) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs
- (2020) Jicheng Yu et al. Nature Biomedical Engineering
- Ultra Rapid Lispro Lowers Postprandial Glucose and More Closely Matches Normal Physiological Glucose Response Compared to Other Rapid Insulin Analogs: A Phase 1 Randomized, Crossover Study
- (2020) Tim Heise et al. DIABETES OBESITY & METABOLISM
- Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
- (2020) Charlotte Boughton et al. BMJ Open
- 236-OR: Molecular and Biological Properties of Insulin Icodec, a New Insulin Analog Designed to Give a Long Half-Life Suitable for Once-Weekly Dosing
- (2020) ERICA NISHIMURA et al. DIABETES
- 105-LB: Evening Oral Insulin (ORMD-0801) Glycemic Effects in Uncontrolled T2DM Patients
- (2020) ROY ELDOR et al. DIABETES
- 115-LB: Oral Insulin–Induced Reduction in Liver Fat Content in T2DM Patients with Nonalcoholic Steatohepatitis
- (2020) MIRIAM KIDRON et al. DIABETES
- Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
- (2020) Thomas Blevins et al. DIABETES CARE
- Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study
- (2020) Leslie Klaff et al. DIABETES OBESITY & METABOLISM
- Molecular engineering of safe and efficacious oral basal insulin
- (2020) Frantisek Hubálek et al. Nature Communications
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
- (2020) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Review: Glucose-sensitive insulin
- (2020) Thomas Hoeg-Jensen Molecular Metabolism
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
- (2019) Jonas Kildegaard et al. PHARMACEUTICAL RESEARCH
- Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia
- (2019) Jinqiang Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Discovery and Development of Liraglutide and Semaglutide
- (2019) Lotte Bjerre Knudsen et al. Frontiers in Endocrinology
- Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs
- (2019) Justin M. Gregory et al. DIABETES OBESITY & METABOLISM
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor–ligand complex
- (2019) Emiko Uchikawa et al. eLife
- Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
- (2019) Stephen C. Bain et al. JOURNAL OF MEDICAL ECONOMICS
- Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus
- (2019) Anand Khedkar et al. Clinical Pharmacology in Drug Development
- Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
- (2019) Hanne Haahr et al. CLINICAL PHARMACOKINETICS
- The cell biology of systemic insulin function
- (2018) Victoria L. Tokarz et al. JOURNAL OF CELL BIOLOGY
- Clinical Evaluation of MK-2640: An Insulin Analog with Glucose-Responsive Properties
- (2018) Alexander W. Krug et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- A biomimetic receptor for glucose
- (2018) Robert A. Tromans et al. Nature Chemistry
- Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis
- (2018) Sanjay Basu et al. Lancet Diabetes & Endocrinology
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Base-Catalyzed Aryl-B(OH)2 Protodeboronation Revisited: From Concerted Proton Transfer to Liberation of a Transient Aryl Anion
- (2017) Paul A. Cox et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Biochemical and cellular properties of insulin receptor signalling
- (2017) Rebecca A. Haeusler et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action
- (2016) S. J. Jacober et al. DIABETES OBESITY & METABOLISM
- Pursuit of a perfect insulin
- (2016) Alexander N. Zaykov et al. NATURE REVIEWS DRUG DISCOVERY
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp
- (2015) Tiffany D. Farmer et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes
- (2015) Justin M. Gregory et al. DIABETES
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
- (2015) Shona J. Livingstone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart
- (2015) Svend Havelund et al. PHARMACEUTICAL RESEARCH
- Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates
- (2015) Danny Hung-Chieh Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance
- (2014) Hanne Haahr et al. CLINICAL PHARMACOKINETICS
- Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog
- (2014) Dale S. Edgerton et al. DIABETES
- Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
- (2014) Robert R. Henry et al. DIABETES CARE
- Insulin Receptor Signaling in Normal and Insulin-Resistant States
- (2014) J. Boucher et al. Cold Spring Harbor Perspectives in Biology
- Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
- (2013) M. C. Moore et al. DIABETES
- How insulin engages its primary binding site on the insulin receptor
- (2013) John G. Menting et al. NATURE
- Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
- (2013) Roy Eldor et al. PLoS One
- Tissue–Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease
- (2012) Christian Rask-Madsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ligand-Controlled Assembly of Hexamers, Dihexamers, and Linear Multihexamer Structures by the Engineered Acylated Insulin Degludec
- (2012) Dorte B. Steensgaard et al. BIOCHEMISTRY
- A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
- (2012) Vinay Bhaskar et al. DIABETES
- Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes
- (2012) G. B. Bolli et al. DIABETES CARE
- The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences
- (2012) P. D. Home DIABETES OBESITY & METABOLISM
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- A Review of 25 Yearsʼ Experience with the NovoPen® Family of Insulin Pens in the Management of Diabetes Mellitus
- (2010) Jacob Hyllested-Winge et al. CLINICAL DRUG INVESTIGATION
- A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects
- (2010) A. Khedkar et al. DIABETES OBESITY & METABOLISM
- In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
- (2010) Mark R. Sommerfeld et al. PLoS One
- Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor
- (2009) Colin W. Ward et al. BIOESSAYS
- Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis
- (2008) E. Mannucci et al. DIABETES OBESITY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now